IEM 1754

Known as: IEM-1754 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2014
024619942014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The action of non-competitive glutamate receptor antagonists on the effects of sleep deprivation has been studied on Krushinskii… (More)
Is this relevant?
2012
2012
The action of noncompetitive blockers of glutamate receptors has been investigated on Krushinski-Molodkina rats genetically-prone… (More)
Is this relevant?
2008
2008
There is numerous experimental and conceptual proof that the extracellular portion of ionotropic glutamate receptors (iGluRs), i… (More)
Is this relevant?
2006
2006
The action of three dicationic drugs, derivatives of adamantane (IEM-1460 and IEM-1754) and phencyclidine (IEM-1925), on… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
1. The kinetics of open channel block of GluR2-containing and GluR2-lacking AMPA receptors (AMPAR) by dicationic compounds (IEM… (More)
Is this relevant?
2000
2000
Pyrilene acts as a central H-cholinoblocker upon intramuscular injection at a dose of 0.02-0.08 mg/kg, and as an NMDA-blocker… (More)
Is this relevant?
1998
1998
We report the presence of binding sites for permeant monovalent cations at the internal and external entrances to the channel of… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
1. The effects of two adamantane derivatives, 1-trimethylammonio-5-(1-adamantane-methyl-ammoniopentane dibromide) (IEM-1460) and… (More)
Is this relevant?
1996
1996
1. The mechanisms by which four adamantane derivatives (IEM-1857, -1592, -1460 and -1754) block the open NMDA-activated channel… (More)
Is this relevant?
1995
1995
We examined the influence of the molecular structure of four novel adamantane derivatives on their ability to block the channels… (More)
Is this relevant?